Claudine Bonder

Prof Claudine Bonder

Research Professor

Centre for Cancer Biology

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Available For Media Comment.

Professor Claudine Bonder OAM is an expert in vascular biology with 25 years experience having trained both in Australia and overseas. She currently heads the Vascular Biology and Cell Trafficking Laboratory at the Centre for Cancer Biology in Adelaide. During her career, Claudine has been awarded the prestigious Early Career Research Award from the Australian Academy of Sciences in 2005, a SA Young Tall Poppy in 2010, was an ASMR Leading Light finalist in 2013, won the Women in Innovation (emerging innovator) in 2016 and in 2025 was awarded a Medal of the Order of Australia.
Research Program Overview:
Blood vessels form an extensive network that transports cells, oxygen and nutrients throughout all tissues and organs. Blood vessels are key components in our fight against disease and improved understanding of endothelial cells (ECs, specialised cells which form the inner lining of blood vessels), will provide new knowledge and novel treatment options for many fatal diseases, including cancer, heart disease and diabetes.
We have world leading research in vasculogenic mimicry (VM), a process wherein cancer cells themselves form vascular-like structures to increase access to the blood supply to assist in tumour growth. In the most aggressive and difficult to treat cancers of the breast, skin and pancreas, increased VM is associated with poor clinical outcome. We have begun to identify novel elements in VM and are now targeting these with an overall aim to provide better outcomes for cancer patients.
Current Research Projects:

Investigating the role of desmoglein-2 in the progression of blood cancers and solid tumours
Understanding the contribution of vasculogenic mimicry in the tumour microenvironment and cancer progression
Defining the gene expression, signalling pathways and spatial proteomics that promote and modulate tumour vasculature and anti-tumour immunity
Advancing CAR-T cells for application to combat solid tumours (Carina Biotech Ltd)

Our expertise in blood vessels, and the endothelial cells which form their inner lining, allows us to critically interrogate diseases such as cancer, cardiovascular disease and diabetes. Our ultimate aim is to understand the fundamental biology of the blood vasculature so that new treatment opportunities for the most debilitating and deadly diseases can be produced to save thousands of lives every year, worldwide.

Year Citation
2025 Liu, J., Geremew, D., Sandeman, L. Y., Nankivell, V. A., Chen, R., Xiang, L., . . . Bursill, C. A. (2025). Development of a Novel Murine Model of In-Stent Neoatherosclerosis. Journal of the American Heart Association, 14(22), e041260.
DOI Scopus1 WoS1 Europe PMC1
2025 Okuda, K. S., Baxter, A. A., Stanley, C. P., & Bonder, C. S. (2025). Vessels in Middle-Earth: Meeting Report from the 2025 Australasian Summit on Vascular Biology and Microcirculation.. Vascular biology (Bristol, England), VB-25-0017.
DOI
2025 Thompson, E. J., Dorward, E. L., Jurrius, K., Nataren, N., Tondl, M., Myo Min, K. K., . . . Bonder, C. S. (2025). Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicry. Molecular Oncology, online(9), 1-20.
DOI Scopus2 WoS2 Europe PMC1
2024 Thompson, E. J., Escarbe, S., Tvorogov, D., Farshid, G., Gregory, P. A., Khew-Goodall, Y., . . . Bonder, C. S. (2024). Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth Factors, 42(2), 49-61.
DOI Scopus2 WoS2 Europe PMC1
2024 Moore, E., Robson, A. J., Crisp, A. R., Cockshell, M. P., Burzava, A. L. S., Ganesan, R., . . . Bonder, C. S. (2024). Study of the Structure of Hyperbranched Polyglycerol Coatings and their Anti-Biofouling and Anti-Thrombotic Applications. Advanced Healthcare Materials, 13(26), 2401545-1-2401545-23.
DOI Scopus2 WoS2 Europe PMC1
2024 Yu, W., Truong, N. T. H., Polara, R., Gargett, T., Tea, M. N., Pitson, S. M., . . . Brown, M. P. (2024). Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma. Clinical & Translational Immunology, 13(7), e1519-1-e1519-20.
DOI Scopus10 WoS11 Europe PMC7
2024 Williamson, A. E., Liyanage, S., Hassanshahi, M., Dona, M. S. I., Toledo-Flores, D., Tran, D. X. A., . . . Psaltis, P. J. (2024). Discovery of an embryonically derived bipotent population of endothelial-macrophage progenitor cells in postnatal aorta. Nature Communications, 15(1), 7097-1-7097-21.
DOI Scopus6 WoS8 Europe PMC6
2023 Myo Min, K. K., Ffrench, C. B., McClure, B. J., Ortiz, M., Dorward, E. L., Samuel, M. S., . . . Bonder, C. S. (2023). Desmoglein-2 as a cancer modulator: friend or foe?. Frontiers in Oncology, 13(1327478), 1327478-1-1327478-15.
DOI Scopus10 WoS11 Europe PMC9
2023 Myo Min, K. K., Ffrench, C. B., Jessup, C. F., Shepherdson, M., Barreto, S. G., & Bonder, C. S. (2023). Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities. Cancers, 15(8), 1-19.
DOI Scopus13 WoS15 Europe PMC13
2023 Scheer, K. G., Ebert, L. M., Samuel, M. S., Bonder, C. S., & Gomez, G. A. (2023). Bevacizumab-Induced Hypertension in Glioblastoma Patients and Its Potential as a Modulator of Treatment Response. Hypertension, 80(8), 1590-1597.
DOI Scopus10 WoS9 Europe PMC9
2023 Bandara, V., Foeng, J., Gundsambuu, B., Norton, T. S., Napoli, S., McPeake, D. J., . . . Barry, S. C. (2023). Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7.. Nat Commun, 14(1), 1-17.
DOI Scopus20 WoS21 Europe PMC18
2022 Ebert, L. M., Vandyke, K., Johan, M. Z., DeNichilo, M., Tan, L. Y., Myo Min, K. K., . . . Bonder, C. S. (2022). Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma. Molecular Oncology, 16(6), 1221-1240.
DOI Scopus11 WoS12 Europe PMC11
2022 Blaszczak, W., Ahmed, A., Leithner, K., Schubert, A., Leech, M., Bonder, C., & Tsagakis, I. (2022). Outlook of women in science: an interview with our authors. Molecular oncology, 16(5), 1047-1056.
DOI
2022 Tan, L. Y., Cockshell, M. P., Moore, E., Myo Min, K. K., Ortiz, M., Johan, M. Z., . . . Bonder, C. S. (2022). Vasculogenic mimicry structures in melanoma support the recruitment of monocytes. OncoImmunology, 11(1), e2043673-1-e2043673-18.
DOI Scopus18 WoS19 Europe PMC19
2022 Burzava, A. L. S., Jasieniak, M., Cockshell, M. P., Voelcker, N. H., Bonder, C. S., Griesser, H. J., & Moore, E. (2022). Attachment of endothelial colony-forming cells onto a surface bearing immobilized anti-CD34 antibodies: Specific CD34 binding versus nonspecific binding. Biointerphases, 17(3), 1-12.
DOI Scopus2 WoS2 Europe PMC1
2022 Myo Min, K. K., Rojas-Canales, D., Penko, D., DeNichilo, M., Cockshell, M. P., Ffrench, C. B., . . . Bonder, C. S. (2022). Desmoglein-2 is important for islet function and β-cell survival. Cell Death and Disease, 13(10), 911-1-911-15.
DOI Scopus7 WoS7 Europe PMC6
2021 Fouladzadeh, A., Dorraki, M., Min, K. K. M., Cockshell, M. P., Thompson, E. J., Verjans, J. W., . . . Abbott, D. (2021). The development of tumour vascular networks. Communications Biology, 4(1, article no. 1111), 1111-1-1111-10.
DOI Scopus20 WoS16 Europe PMC16
2021 Yang, G. N., Strudwick, X. L., Bonder, C. S., Kopecki, Z., & Cowin, A. J. (2021). Increased expression of flightless I in cutaneous squamous cell carcinoma affects wnt/β-catenin signaling pathway. International Journal of Molecular Sciences, 22(24), 13203-1-13203-14.
DOI Scopus2 WoS1 Europe PMC3
2021 Genovesi, L. A., Puttick, S., Millar, A., Kojic, M., Ji, P., Lagendijk, A. K., . . . Wainwright, B. J. (2021). Patient derived orthotopic xenograft models of medulloblastoma lack a functional blood brain barrier. Neuro-Oncology, 23(5), 732-742.
DOI Scopus20 WoS18 Europe PMC15
2021 Martini, C., DeNichilo, M., King, D. P., Cockshell, M. P., Ebert, B., Dale, B., . . . Bonder, C. S. (2021). CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix. BMC Cancer, 21(1), 765-1-765-14.
DOI Scopus27 WoS26 Europe PMC22
2020 Yang, G. N., Strudwick, X. L., Bonder, C., Kopecki, Z., & Cowin, A. J. (2020). Effect of flightless I expression on epidermal stem cell niche during wound repair. Advances in Wound Care, 9(4), 161-173.
DOI Scopus11 WoS10 Europe PMC9
2020 Ebert, L. M., Yu, W., Gargett, T., Toubia, J., Kollis, P. M., Tea, M. N., . . . Brown, M. P. (2020). Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy. Clinical and Translational Immunology, 9(10), 1-24.
DOI Scopus51 WoS48 Europe PMC47
2020 Dorraki, M., Fouladzadeh, A., Allison, A., Bonder, C., & Abbott, D. (2020). Angiogenic Networks in Tumors—Insights via Mathematical Modeling. IEEE Access, 8, 43215-43228.
DOI Scopus9 WoS8
2020 Martini, C., Thompson, E. J., Hyslop, S. R., Cockshell, M. P., Dale, B. J., Ebert, L. M., . . . Bonder, C. S. (2020). Platelets disrupt vasculogenic mimicry by cancer cells. Scientific Reports, 10(1), 5869-1-5869-18.
DOI Scopus25 WoS21 Europe PMC20
2020 Burzava, A. L. S., Jasieniak, M., Cockshell, M. P., Voelcker, N. H., Bonder, C. S., Griesser, H. J., & Moore, E. (2020). Surface-grafted hyperbranched polyglycerol coating: varying extents of fouling resistance across a range of proteins and cells. ACS Applied Bio Materials, 3(6), 3718-3730.
DOI Scopus11 WoS10 Europe PMC7
2020 Flemming, J. P., Hill, B. L., Haque, M. W., Raad, J., Bonder, C. S., Harshyne, L. A., . . . Mahoney, M. Y. G. (2020). miRNA- and cytokine-associated extracellular vesicles mediate squamous cell carcinomas. Journal of Extracellular Vesicles, 9(1, article no. 1790159), 1-22.
DOI Scopus51 WoS48 Europe PMC44
2019 Elder, A. S. F., Bersten, A. D., Saccone, G. T. P., Bonder, C. S., & Dixon, D. L. (2019). Prevention and amelioration of rodent ventilation-induced lung injury with either prophylactic or therapeutic feG administration. Lung, 197(5), 671-680.
DOI Scopus3 WoS3 Europe PMC3
2019 Burzava, A. L. S., Forget, A., Harding, F. J., Cockshell, M. P., Penko, D., Rouzaud, C., . . . Voelcker, N. H. (2019). Replica moulded poly(dimethylsiloxane) microwell arrays induce localized endothelial cell immobilization for coculture with pancreatic islets. Biointerphases, 14(1), 9 pages.
DOI Scopus1
2019 Vidanapathirana, A. K., Pullen, B. J., Zhang, R., Duong, M. N., Goyne, J. M., Zhang, X., . . . Psaltis, P. J. (2019). A novel ruthenium-based molecular sensor to detect endothelial nitric oxide. Scientific Reports, 9(1, article no. 1720), 1720-1-1720-16.
DOI Scopus9 WoS8 Europe PMC8
2019 Harper, R. L., Maiolo, S., Ward, R. J., Savaglia, J., Cockshell, M. P., Bonder, C. S., & Reynolds, P. N. (2019). BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo. Respirology, 24(11), 1095-1103.
DOI Scopus26 WoS23 Europe PMC19
2019 Toledo-Flores, D., Williamson, A., Schwarz, N., Fernando, S., Dimasi, C., Witt, T. A., . . . Psaltis, P. J. (2019). Vasculogenic properties of adventitial Sca-1⁺CD45⁺ progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis. Scientific Reports, 9(1), 7286-1-7286-15.
DOI Scopus22 WoS21 Europe PMC20
2019 Neubauer, H. A., Tea, M. N., Zebol, J. R., Gliddon, B. L., Stefanidis, C., Moretti, P. A. B., . . . Pitson, S. M. (2019). Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma. Oncogene, 38(8), 1151-1165.
DOI Scopus26 WoS24 Europe PMC18
2018 Lidgerwood, G. E., Pitson, S. M., Bonder, C., & Pébay, A. (2018). Roles of lysophosphatidic acid and sphingosine-1-phosphate in stem cell biology. Progress in Lipid Research, 72, 42-54.
DOI Scopus34 WoS33 Europe PMC30
2018 Chan, D., Green, S., Fiatarone Singh, M. A., Barnard, R., Bonder, C. S., & Cheema, B. S. (2018). Effect of intradialytic resistance training on pulse wave velocity and associated cardiovascular disease biomarkers in end stage renal disease. Nephrology, 23(11), 1055-1062.
DOI Scopus7 WoS8 Europe PMC6
2018 Cabezas, S., Bracho, G., Aloia, A. L., Adamson, P. J., Bonder, C. S., Smith, J. R., . . . Carr, J. M. (2018). Dengue virus induces increased activity of the complement alternative pathway in infected cells. Journal of Virology, 92(14), e00633-18-1-e00633-18-20.
DOI Scopus33 WoS30 Europe PMC27
2018 Hofma, B., Wardill, H., Mavrangelos, C., Campaniello, M., Dimasi, D., Bowen, J., . . . Hughes, P. (2018). Colonic migrating motor complexes are inhibited in acute tri-nitro benzene sulphonic acid colitis. PLoS ONE, 13(6), e0199394-1-e0199394-15.
DOI Scopus15 WoS14 Europe PMC12
2018 Hercus, T., Kan, W., Broughton, S., Tvorogov, D., Ramshaw, H., Sandow, J., . . . Lopez, A. (2018). Role of the β common (βc) family of cytokines in health and disease. Cold Spring Harbor Perspectives in Biology, 10(6), a028514.
DOI Scopus42 WoS33 Europe PMC31
2017 Heng, S., Reineck, P., Vidanapathirana, A., Pullen, B., Drumm, D., Ritter, L., . . . Abell, A. (2017). Rationally designed probe for reversible sensing of zinc and application in cells. ACS Omega, 2(9), 6201-6210.
DOI Scopus26 WoS25 Europe PMC11
2017 Etemadi, N., Chopin, M., Anderton, H., Tanzer, M. C., Rickard, J. A., Abeysekera, W., . . . Silke, J. (2017). Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1.. eLife, 6, e29849.
DOI Scopus6 Europe PMC5
2017 Burzava, A. L. S., Jasieniak, M., Cockshell, M. P., Bonder, C. S., Harding, F. J., Griesser, H. J., & Voelcker, N. H. (2017). Affinity binding of EMR2 expressing cells by surface-grafted chondroitin sulfate B. Biomacromolecules, 18(6), 1697-1704.
DOI Scopus5 WoS5 Europe PMC3
2017 Bihari, S., Dixon, D., Lawrence, M., De Bellis, D., Bonder, C., Dimasi, D., & Bersten, A. (2017). Fluid-induced lung injury-role of TRPV4 channels. Pflugers Archiv European Journal of Physiology, 469(9), 1121-1134.
DOI Scopus25 WoS22 Europe PMC24
2017 Tan, L. Y., Martini, C., Fridlender, Z. G., Bonder, C. S., Brown, M. P., & Ebert, L. M. (2017). Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?. Clinical and Translational Immunology, 6(3), e134-1-e134-9.
DOI Scopus27 WoS28 Europe PMC25
2017 Rojas-Canales, D., Penko, D., Min, K., Parham, K., Peiris, H., Haberberger, R., . . . Jessup, C. (2017). Local sphingosine kinase 1 activity improves islet transplantation. Diabetes, 66(5), 1301-1311.
DOI Scopus7 WoS7 Europe PMC4
2016 Dalilottojari, A., Delalat, B., Harding, F. J., Cockshell, M. P., Bonder, C. S., & Voelcker, N. H. (2016). Porous silicon-based cell microarrays: optimizing human endothelial cell-material surface interactions and bioactive release. Biomacromolecules, 17(11), 3724-3731.
DOI Scopus7 WoS6 Europe PMC6
2016 Pastore, M., Studier, H., Bonder, C., & Roberts, M. (2016). Non-invasive metabolic imaging of melanoma progression. Experimental Dermatology, 26(7), 1-8.
DOI Scopus40 WoS35 Europe PMC17
2016 Harper, R., Reynolds, A., Bonder, C., & Reynolds, P. (2016). BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling. Respirology, 21(4), 727-733.
DOI Scopus40 WoS39 Europe PMC32
2016 Dimasi, D., Pitson, S., & Bonder, C. (2016). Examining the role of sphingosine kinase-2 in the regulation of endothelial cell barrier integrity. Microcirculation, 23(3), 248-265.
DOI Scopus11 WoS9 Europe PMC10
2016 Sun, W. Y., Dimasi, D. P., Pitman, M. R., Zhuang, Y., Heddle, R., Pitson, S. M., . . . Bonder, C. S. (2016). Topical application of fingolimod perturbs cutaneous inflammation. Journal of Immunology, 196(9), 3854-3864.
DOI Scopus14 WoS13 Europe PMC14
2016 Moore, E., Zill, A., Anderson, C., Jochem, A., Zimmerman, S., Bonder, C., . . . Voelcker, N. (2016). Synthesis and Conjugation of Alkyne-Functional Hyperbranched Polyglycerols. Macromolecular Chemistry and Physics, 217(20), 2252-2261.
DOI Scopus11 WoS11
2016 Ebert, L. M., Tan, L. Y., Johan, M. Z., Min, K. K. M., Cockshell, M. P., Parham, K. A., . . . Bonder, C. S. (2016). A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis, 19(4), 463-486.
DOI Scopus38 WoS39 Europe PMC30
2016 Tan, L., Mintoff, C., Johan, M., Ebert, B., Fedele, C., Zhang, Y., . . . Ebert, L. (2016). Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome. Oncotarget, 7(29), 46492-46508.
DOI Scopus46 WoS46 Europe PMC42
2016 Neubauer, H. A., Pham, D. H., Zebol, J. R., Moretti, P. A. B., Peterson, A. L., Leclercq, T. M., . . . Pitson, S. M. (2016). An oncogenic role for sphingosine kinase 2. Oncotarget, 7(40), 64886-64899.
DOI Scopus54 WoS50 Europe PMC52
2016 Pulford, E., Hocking, A., Griggs, K., McEvoy, J., Bonder, C., Henderson, D. W., & Klebe, S. (2016). Vasculogenic mimicry in malignant mesothelioma: an experimental and immunohistochemical analysis. Pathology, 48(7), 650-659.
DOI Scopus16 WoS16 Europe PMC15
2016 Cockshell, M. P., & Bonder, C. S. (2016). Isolation and culture of human CD133+ non-adherent endothelial forming cells. Bio-protocol, 6(7, article no. e1772), 1-12.
DOI
2015 Etemadi, N., Chopin, M., Anderton, H., Tanzer, M., Rickard, J., Abeysekera, W., . . . Silke, J. (2015). TRAF2 regulates TNF and NF-kB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1. eLife, 4(e10592), e10592-1-e10592-27.
DOI Scopus89 WoS86 Europe PMC76
2015 Pitman, M., Powell, J., Coolen, C., Moretti, P., Zebol, J., Pham, D., . . . Pitson, S. (2015). A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties. Oncotarget, 6(9), 7065-7083.
DOI Scopus65 WoS64 Europe PMC56
2015 Moldenhauer, L., Cockshell, M., Frost, L., Parham, K., Tvorogov, D., Tan, L., . . . Bonder, C. (2015). Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic properties. Stem Cell Research, 14(3), 380-395.
DOI Scopus17 WoS18 Europe PMC13
2015 Calvert, J., Helbig, K., Dimasi, D., Cockshell, M., Beard, M., Pitson, S., . . . Carr, J. (2015). Dengue virus infection of primary endothelial cells induces innate immune responses, changes in endothelial cells function and is restricted by interferon-stimulated responses. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 35(8), 654-665.
DOI Scopus32 WoS29 Europe PMC26
2015 Parham, K., Zebol, J., Tooley, K., Sun, W., Moldenhauer, L., Cockshell, M., . . . Bonder, C. (2015). Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis. The FASEB Journal, 29(9), 3638-3653.
DOI Scopus82 WoS77 Europe PMC70
2015 Bonder, C. S., & Pitson, S. M. (2015). Sphingolipids: who's controlling who in disease?. Immunology and Cell Biology, 93(9), 767-768.
DOI Scopus2 WoS2 Europe PMC2
2015 Aloia, A., Abraham, A., Bonder, C., Pitson, S., & Carr, J. (2015). Dengue virus-induced inflammation of the endothelium and the potential roles of sphingosine kinase-1 and microRNAs. Mediators of Inflammation, 2015(509306), 509306-1-509306-13.
DOI Scopus23 WoS23 Europe PMC17
2015 Penko, D., Rojas-Canales, D., Mohanasundaram, D., Peiris, H., Sun, W., Drogemuller, C., . . . Jessup, C. (2015). Endothelial progenitor cells enhance islet engraftment, influence β-cell function and modulate islet connexin 36 expression. Cell Transplantation, 24(1), 37-48.
DOI Scopus29 WoS27 Europe PMC24
2014 Hanf, W., Bonder, C., & Coates, P. (2014). Transplant glomerulopathy: the interaction of HLA antibodies and endothelium. Journal of Immunology Research, 2014(549315), 549315-1-549315-11.
DOI Scopus23 WoS22 Europe PMC20
2014 Peiris, H., Bonder, C., Coates, P., Keating, D., & Jessup, C. (2014). The β-cell/EC axis: How do islet cells talk to each other?. Diabetes, 63(1), 3-11.
DOI Scopus92 WoS83 Europe PMC79
2014 Ruzehaji, N., Kopecki, Z., Melville, E., Appleby, S., Bonder, C., Arkell, R., . . . Cowin, A. (2014). Attenuation of flightless I improves wound healing and enhances angiogenesis in a murine model of type 1 diabetes. Diabetologia, 57(2), 402-412.
DOI Scopus30 WoS28 Europe PMC25
2014 Parham, K. A., Pitson, S. M., & Bonder, C. S. (2014). Regulation of EPCs: The Gateway to Blood Vessel Formation. New journal of science, 2014(972043), 1-16.
DOI
2013 Carr, J., Mahalingam, S., Bonder, C., & Pitson, S. (2013). Sphingosine kinase 1 in viral infections. Reviews in Medical Virology, 23(2), 73-84.
DOI Scopus44 WoS42 Europe PMC37
2013 Cowin, A., Ruzehaji, N., Kopecki, Z., Sue, A., Bonder, C., & Fitridge, R. (2013). Reducing flightless I protein improves healing in a murine model of type 1 diabetes through increased angiogenesis. Wound repair and regeneration, 21(6), 61.
2013 Dimasi, D., Sun, W., & Bonder, C. (2013). Neutrophil interactions with the vascular endothelium. International Immunopharmacology, 17(4), 1167-1175.
DOI Scopus49 WoS46 Europe PMC40
2013 Bonder, C., & Ebert, L. (2013). Fos-icking for control of angiogenesis: Increasing the longevity of peritoneal dialysis. Kidney International, 84(6), 1065-1067.
DOI Scopus6 WoS6 Europe PMC5
2013 Limaye, V., Bonder, C., Sun, W., Lester, S., Roberts-Thomson, P., & Blumbergs, P. (2013). Levels of soluble adhesion molecules and their associations in inflammatory myositis. International Journal of Rheumatic Diseases, 16(1), 99-101.
DOI Scopus4 WoS4 Europe PMC3
2012 Appleby, S., Cockshell, M., Pippal, J., Thompson, E., Barrett, J., Tooley, K., . . . Bonder, C. (2012). Characterization of a distinct population of circulating human non-adherent endothelial forming cells and their recruitment via intercellular adhesion molecule-3. PLoS One, 7(11), 1-15.
DOI Scopus21 WoS21 Europe PMC17
2012 Broughton, S., Dhagat, U., Hercus, T., Nero, T., Grimbaldeston, M., Bonder, C., . . . Parker, M. (2012). The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling. Immunological Reviews, 250(1), 277-302.
DOI Scopus211 WoS194 Europe PMC179
2012 Sun, W., Abeynaike, L., Escarbe, S., Smith, C., Pitson, S., Hickey, M., & Bonder, C. (2012). Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent. American Journal of Pathology, 180(4), 1740-1750.
DOI Scopus23 WoS24 Europe PMC22
2012 Sun, W., & Bonder, C. (2012). Sphingolipids: a potential molecular approach to treat allergic inflammation. Journal of Allergy, 2012(154174), 154174-1-154174-14.
DOI Europe PMC4
2011 Pitson, S., Powell, J., & Bonder, C. (2011). Regulation of sphingosine kinase in hematological malignancies and other cancers. Anti-Cancer Agents in Medicinal Chemistry, 11(9), 799-809.
DOI Scopus22 WoS22 Europe PMC19
2011 Sen, S., Coates, P. T. H., Bonder, C. S., & Mcdonald, S. P. (2011). THE INTERACTION OF URAEMIC TOXINS AND ENDOTHELIAL PROGENITOR CELLS IN THE PROGRESSION OF CARDIOVASCULAR DISEASE. NEPHROLOGY, 16, 40.
2011 Jessup, C., Bonder, C., Pitson, S., & Coates, P. (2011). The sphingolipid rheostat: A potential target for improving pancreatic islet survival and function. Endocrine, Metabolic & Immune Disorders - Drug Targets, 11(4), 262-272.
DOI Scopus29 Europe PMC28
2011 Barrett, J., Parham, K., Pippal, J., Cockshell, M., Moretti, P., Brice, S., . . . Bonder, C. (2011). Over-expression of sphingosine kinase-1 enhances a progenitor phenotype in human endothelial cells. Microcirculation, 18(7), 583-597.
DOI Scopus10 WoS10 Europe PMC9
2011 Penko, D., Mohanasundaram, D., Sen, S., Drogemuller, C., Mee, C., Bonder, C., . . . Jessup, C. (2011). Incorporation of endothelial progenitor cells into mosaic pseudoislets. Islets, 3(3), 73-79.
DOI Scopus28 WoS28 Europe PMC22
2011 Sen, S., McDonald, S., Coates, P., & Bonder, C. (2011). Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clinical Science, 120(7-8), 263-283.
DOI Scopus192 WoS176 Europe PMC146
2010 Wang, H., Paton, J., Thorpe, C., Bonder, C., Sun, W., & Paton, A. (2010). Tissue factor-dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli. Journal of Infectious Diseases, 202(9), 1415-1423.
DOI Scopus12 WoS10 Europe PMC9
2010 Sun, W., Pitson, S., & Bonder, C. (2010). Tumor necrosis factor-induced neutrophil adhesion occurs via sphingosine kinase-1-dependent activation of endothelial α₅β₁ integrin. American Journal of Pathology, 177(1), 436-446.
DOI Scopus32 WoS30 Europe PMC28
2009 Gamble, J., Sun, W., Li, X., Hahn, C., Pitson, S., Vadas, M., & Bonder, C. (2009). Sphingosine kinase-1 associates with Integrin alpha(V)beta(3) to mediate endothelial cell survival. American Journal of Pathology, 175(5), 2217-2225.
DOI Scopus17 WoS14 Europe PMC14
2009 Bonder, C., Sun, W., Matthews, T., Cassano, C., Li, X., Ramshaw, H., . . . Gamble, J. (2009). Sphingosine kinase regulates the rate of endothelial progenitor cell differentiation. Blood, 113(9), 2108-2117.
DOI Scopus39 WoS37 Europe PMC34
2009 Sen, S., Mcdonald, S. P., Coates, P. T. H., & Bonder, C. S. (2009). IN VITRO ENDOTHELIAL CELL TUBE-FORMING CAPACITY REDUCED BY TRANSPLANT SERA, BUT MIGRATION INCREASED BY HAEMODIALYSIS SERA. NEPHROLOGY, 14, A41-A42.
2009 Bonder, C. S., & Sun, W. Y. (2009). Sphingosine kinase-1 mediates TNF activation of the integrin VLA-5 for leukocyte adhesion. JOURNAL OF IMMUNOLOGY, 182, 1 page.
2008 Norman, M., Hwang, J., Hulliger, S., Bonder, C., Yamanouchi, J., Santamaria, P., & Kubes, P. (2008). Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response. American Journal of Pathology, 172(6), 1638-1649.
DOI Scopus42 WoS43 Europe PMC36
2008 Li, X., Stankovic, M., Bonder, C., Hahn, C., Parsons, M., Pitson, S., . . . Gamble, J. (2008). Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood, 111(7), 3489-3497.
DOI Scopus77 WoS70 Europe PMC61
2008 Kerfoot, S., Andonegui, G., Bonder, C. S., & Liu, L. (2008). Exogenous stromal cell-derived factor-1 induces modest leukocyte recruitment in vivo. American journal of physiology : heart and circulatory physiology, 294(6), 2524-2534.
DOI Scopus10 WoS10 Europe PMC7
2007 Pebay, A., Bonder, C., & Pitson, S. (2007). Stem cell regulation by lysophospholipids. Prostaglandins & Other Lipid Mediators, 84(3-4), 83-97.
DOI Scopus96 WoS89 Europe PMC70
2006 Bonder, C. S., Clark, S. R., Norman, M. U., Johnson, P., & Kubes, P. (2006). Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere. Blood, 107(12), 4798-4806.
DOI Scopus75 WoS70 Europe PMC69
2006 Kerfoot, S. M., Norman, M. U., Lapointe, B. M., Bonder, C. S., Zbytnuik, L., & Kubes, P. (2006). Reevaluation of P-selectin and α4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. Journal of Immunology, 176(10), 6225-6234.
DOI Scopus84 WoS77 Europe PMC70
2005 Mangan, P. R., O'Quinn, D., Harrington, L., Bonder, C. S., Kubes, P., Kucik, D. F., . . . Weaver, C. T. (2005). Both Th1 and Th2 cells require P-selectin glycoprotein ligand-1 for optimal rolling on inflamed endothelium. American Journal of Pathology, 167(6), 1661-1675.
DOI Scopus23 WoS23 Europe PMC20
2005 Bonder, C. S., Norman, M. U., Swain, M. G., Zbytnuik, L. D., Yamanouchi, J., Santamaria, P., . . . Kubes, P. (2005). Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: A role for alpha-4 integrin and vascular adhesion protein-1. Immunity, 23(2), 153-163.
DOI Scopus139 WoS133 Europe PMC115
2005 Bonder, C. S., Norman, M. U., MacRae, T., Mangan, P. R., Weaver, C. T., Bullard, D. C., . . . Kubes, P. (2005). P-selectin can support both Th1 and Th2 lymphocyte rolling in the intestinal microvasculature. American Journal of Pathology, 167(6), 1647-1660.
DOI Scopus33 WoS27 Europe PMC25
2004 Zanardo, R. C. O., Bonder, C. S., Hwang, J. M., Andonegui, G., Liu, L., Vestweber, D., . . . Kubes, P. (2004). A down-regulatable E-selectin ligand is functionally important for PSGL-1-independent leukocyte-endothelial cell interactions. Blood, 104(12), 3766-3773.
DOI Scopus26 WoS25 Europe PMC20
2004 Bonder, C. S., Knight, D., Hernandez-Saavedra, D., McCord, J. M., & Kubes, P. (2004). Chimeric SOD2/3 inhibits at the endothelial-neutrophil interface to limit vascular dysfunction in ischemia-reperfusion. American Journal of Physiology Gastrointestinal and Liver Physiology, 287(3 50-3), G676-G684.
DOI Scopus17 WoS14 Europe PMC11
2004 Bonder, C. S., Ajuebor, M. N., Zbytnuik, L. D., Kubes, P., & Swain, M. G. (2004). Essential Role for Neutrophil Recruitment to the Liver in Concanavalin A-Induced Hepatitis. Journal of Immunology, 172(1), 45-53.
DOI Scopus180 WoS171 Europe PMC149
2004 Kerfoot, S. M., Long, E. M., Hickey, M. J., Andonegui, G., Lapointe, B. M., Zanardo, R. C. O., . . . Kubes, P. (2004). TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. Journal of Immunology, 173(11), 7070-7077.
DOI Scopus189 WoS176 Europe PMC159
2003 Andonegui, G., Bonder, C. S., Green, F., Mullaly, S. C., Zbytnuik, L., Raharjo, E., & Kubes, P. (2003). Erratum: Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs (Journal of Clininal Investigation (2003) 111 (1011-1020)). Journal of Clinical Investigation, 112(8), 1264.
DOI Scopus7 WoS6
2003 Andonegui, G., Bonder, C. S., Green, F., Mullaly, S. C., Zbytnuik, L., Raharjo, E., & Kubes, P. (2003). Endothelium-derived toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. Journal of Clinical Investigation, 111(7), 1011-1020.
DOI Scopus374 WoS352 Europe PMC298
2003 Bonder, C. S., & Kubes, P. (2003). The future of GI and liver research: Editorial perspectives II. Modulating leukocyte recruitment to splanchnic organs to reduce inflammation. American Journal of Physiology Gastrointestinal and Liver Physiology, 284(5 47-5), G729-G733.
DOI Scopus6 WoS6 Europe PMC5
2002 Bonder, C. S., Davies, K. V. L., Hosszu, E. K., Finlay-Jones, J. J., & Hart, P. H. (2002). IFN-γ downregulates interleukin-4 functional activity on monocytes by multiple mechanisms. Journal of Interferon and Cytokine Research, 22(3), 287-293.
DOI Scopus10 WoS10 Europe PMC9
2002 Bonder, C. S., Davies, K. V. L., Liu, X., Hertzog, P. J., Woodcock, J. M., Finlay-Jones, J. J., & Hart, P. H. (2002). Endogenous interferon-α production by differentiating human monocytes regulates expression and function of the IL-2/IL-4 receptor γ chain. Cytokine, 17(4), 187-196.
DOI Scopus3 WoS3 Europe PMC4
2001 Bonder, C. S., Hart, P. H., Davies, K. V. L., Burkly, L. C., Finlay-Jones, J. J., & Woodcock, J. M. (2001). Characterization of IL-4 receptor components expressed on monocytes and mocyte-derived macrophages: Variation associated with differential signaling by IL-4. Growth Factors, 19(4), 207-218.
DOI Scopus5 WoS5 Europe PMC5
1999 Hart, P. H., Bonder, C. S., Balogh, J., Dickensheets, H. L., Donnelly, R. P., & Finlay-Jones, J. J. (1999). Differential responses of human monocytes and macrophages to IL-4 and IL-13. Journal of Leukocyte Biology, 66(4), 575-578.
DOI Scopus85 WoS81 Europe PMC63
1999 Hart, P. H., Bonder, C. S., Balogh, J., Dickensheets, H. L., Vazquez, N., Davies, K. V. L., . . . Donnelly, R. P. (1999). Diminished responses to IL-13 by human monocytes differentiated in vitro: Role of the IL-13Rα1 chain and STAT6. European Journal of Immunology, 29(7), 2087-2097.
DOI Scopus17 WoS15 Europe PMC11
1997 Iversen, P., Hart, P., Bonder, C., & Lopez, A. (1997). Interleukin (IL)-10, but not IL-4 or IL-13, inhibits cytokine production and growth in juvenile myelomonocytic leukemic cells.. Cancer Research, 57(3), 476-480.
Scopus14 WoS16 Europe PMC9
1996 Hart, P. H., Bonder, C. S., Jones, C. A., & Finlay-Jones, J. J. (1996). Control of major histocompatibility complex class II expression on human monocytes by interleukin-4: Regulatory effect of lipopolysaccharide. Immunology, 89(4), 599-605.
DOI Scopus17 WoS18 Europe PMC12

Year Citation
2006 Bonder, C. S., & Kubes, P. (2006). Capture and Rolling: Selectins and Their Ligands. In Leukocyte Trafficking Molecular Mechanisms Therapeutic Targets and Methods (pp. 14-35). Wiley.
DOI Scopus1

Year Citation
2024 Ffrench, C. B., Min, K. K. M., DeNichilo, M., Cockshell, M. P., Dorward, E. L., Thompson, E. J., . . . Bonder, C. S. (2024). Desmoglein-2 is a regulator of pancreatic ductal adenocarcinoma progression. In CANCER RESEARCH Vol. 84 (pp. 3 pages). MA, Boston: AMER ASSOC CANCER RESEARCH.
DOI
2022 Bandara, V., Mills, S., Thompson, E., Tan, L., Gundsambuu, B., Napoli, S., . . . Barry, S. (2022). Pre-clinical validation of a LGR5-targeting CAR-T against colorectal cancer.. In CANCER RESEARCH Vol. 82 (pp. 1 page). LA, New Orleans: AMER ASSOC CANCER RESEARCH.
2022 Thompson, E. J., Bandara, V., Sadlon, T., Gundsambuu, B., Tan, L. Y., Ricciardelli, C., . . . Bonder, C. S. (2022). Real-time cytotoxicity assays as a pre-clinical screening tool for LGR5-targeting CAR-T cells for treatment of solid tumors. In CANCER RESEARCH Vol. 82 (pp. 1 page). LA, New Orleans: AMER ASSOC CANCER RESEARCH.
2022 Thompson, E. J., Bandara, V., Sadlon, T., Gundsambuu, B., Tan, L. Y., Ricciardelli, C., . . . Bonder, C. S. (2022). Real-time cytotoxicity assays as a pre-clinical screening tool for LGR5-targeting CAR-T cells for treatment of solid tumors.. In CANCER RESEARCH Vol. 82 (pp. 1 page). LA, New Orleans: AMER ASSOC CANCER RESEARCH.
2022 Bandara, V., Mills, S., Thompson, E., Tan, L., Gundsambuu, B., Napoli, S., . . . Barry, S. (2022). Pre-clinical validation of a LGR5-targeting CAR-T against colorectal cancer. In CANCER RESEARCH Vol. 82 (pp. 1 page). LA, New Orleans: AMER ASSOC CANCER RESEARCH.
2018 Harper, R. L., Maiolo, S. A., Cockshell, M., Lim, R., Greening, D. W., Bonder, C. S., & Reynolds, P. N. (2018). The Role of Peripheral Blood Derived Outgrowth Endothlial Cells and Their Exosomes in the Progression and Treatment of Pulmonary Arterial Hypertension. In MOLECULAR THERAPY Vol. 26 (pp. 352-353). Chicago, IL: CELL PRESS.
2016 Harper, R. L., Bonder, C. S., & Reynolds, P. N. (2016). BMPR2 Augmented EPC Delivery in a Rat Monocrotaline Induced PAH Model Alters Smad Signalling Profiles. In Proceedings of the American Thoracic Society. San Francisco.
2016 Harper, R., Ward, R., Bonder, C., & Reynolds, P. (2016). SMAD SIGNALLING PROFILES ARE ALTERED FOLLOWING BMPR2 AUGMENTED EPC DELIVERY IN A RAT MONOCROTALINE INDUCED PAH MODEL. In RESPIROLOGY Vol. 21 (pp. 89). WILEY-BLACKWELL.
2015 Harper, R. L., Bonder, C. S., & Reynolds, P. N. (2015). Up-regulation of BMPR2 in Rat Derived Endothelial Progenitor Cells Leads to the Attenuation of PAH in a MCT Rat Model. In Proceedings of the American Thoracic Society. Denver, CO, US: American Thoracic Society.
2015 Harper, R. L., Ward, R., Bonder, C. S., & Reynolds, P. N. (2015). Smad and Non Smad Signalling in PAH Following BMPR2 Gene Delivery. In Proceedings of the American Thoracic Society. Denver, CO, US: American Thoracic Society.
2015 Rojas-Canales, D., Penko, D., Peiris, H., Keating, D., Pitson, S., Drogemuller, C. J., . . . Jessup, C. J. (2015). Sphingosine kinase 1 is vital for the function of islets post transplantation. In XENOTRANSPLANTATION Vol. 22 (pp. S136). Melbourne, AUSTRALIA: WILEY-BLACKWELL.
2015 Rojas-Canales, D., Penko, D., Peiris, H., Keating, D., Pitson, S., Drogemuller, C. J., . . . Jessup, C. J. (2015). SPHINGOSINE KINASE 1 IS VITAL FOR THE FUNCTION OF ISLETS POST TRANSPLANTATION.. In TRANSPLANTATION Vol. 99 (pp. S225). Melbourne, AUSTRALIA: LIPPINCOTT WILLIAMS & WILKINS.
2014 Harper, R., Bonder, C., & Reynolds, P. (2014). ISOLATION AND CHARACTERIZATION OF A DEFINED POPULATION OF ENDOTHELIAL PROGENITOR CELLS FROM THE LEFT VENTRICLE: A PILOT STUDY. In RESPIROLOGY Vol. 19 (pp. 95). WILEY-BLACKWELL.
2011 Penko, D., Mee, C., Mohanasundaram, D., Coates, P. T. H., Bonder, C. S., & Jessup, C. F. (2011). INCORPORATION OF RAT VASCULAR PROGENITOR CELLS INTO MOSAIC ISLET CLUSTERS. In IMMUNOLOGY AND CELL BIOLOGY Vol. 89 (pp. A34). ANU Campus, Canberra, AUSTRALIA: NATURE PUBLISHING GROUP.
2011 Penko, D., Mee, C., Mohanasundaram, D., Coates, P., Bonder, C., & Jessup, C. (2011). Incorporation of rat vascular progenitor cells into mosaic islet clusters to promote engraftment of transplanted pancreatic islets. In 13th World Congress of the International Pancreas and Islet Transplant Association (pp. 0 pages). Prague, Czech Republic.
2009 Jessup, C. F., Mohanasundaram, D., Mee, C., Sun, W. Y., Drogemuller, C., Milner, C. R., . . . Coates, P. T. H. (2009). Co-transplantation of rat endothelial progenitor cells to enhance the engraftment of pancreatic islets. In XENOTRANSPLANTATION Vol. 16 (pp. 412). Venice, ITALY: WILEY-BLACKWELL PUBLISHING, INC.

Year Citation
2022 Thompson, E. J., Bandara, V., Sadlon, T., Gundsambuu, B., Tan, L. Y., Ricciardelli, C., . . . Bonder, C. S. (2022). Real-time cytotoxicity assays as a pre-clinical screening tool for LGR5-targeting CAR-T cells for treatment of solid tumors. Poster session presented at the meeting of Cancer Research. US: American Association for Cancer Research.
DOI
2022 Bandara, V., Mills, S., Thompson, E., Tan, L., Gundsambuu, B., Napoli, S., . . . Barry, S. (2022). Pre-clinical validation of a LGR5-targeting CAR-T against colorectal cancer. Poster session presented at the meeting of Cancer Research. US: American Association for Cancer Research.
DOI
2019 Maiolo, S., Seyfang, J., Cockshell, M., Bonder, C., Harper, R., & Reynolds, P. N. (2019). The Effect of Hypoxia on Blood Outgrowth Endothelial Cells from Pulmonary Arterial Hypertension Patients. Poster session presented at the meeting of AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. US: AMER THORACIC SOC.
2019 Williamson, A., Toledo, D. F., Schwarz, N., Fernando, S., Dimasi, C., Liyanage, S., . . . Psaltis, P. J. (2019). Postnatal mouse aorta contains yolk sac-derived haemangioblasts with myeloid and endothelial plasticity and vasculogenic capacity. Poster session presented at the meeting of European Heart Journal. Paris, France: Oxford University Press.
2019 Seyfang, J., Maiolo, S., Harper, R., Greening, D., Bonder, C., & Reynolds, P. N. (2019). PAH patients have upregulated SPARC in exosomes compared to controls. Poster session presented at the meeting of American journal of respiratory and critical care medicine. US: American Thoracic Society.
2017 Rojas-Canales, D., Penko, D., Nitschke, J., Sivanathan, K., Michaela, W., Grey, S., . . . Coates, P. (2017). NRG mice provide a stable and functional host for human islets and accessory cells in a diabetic transplant model. Poster session presented at the meeting of International Pancreas and Islet Transplantation Society. Oxford, London: The Review of DIABETIC STUDIES.
2017 Burzava, A. L., Moore, E., Cockcshell, M. P., Harding, F. J., Bonder, C. S., & Voelcker, N. (2017). A LOW-FOULING POLYMER COATING COMBINED WITH KEY BIOMOLECULES AS AN ENDOTHELIAL CELL SELECTIVE PLATFORM FOR STENTS. Poster session presented at the meeting of CYTOTHERAPY. ELSEVIER SCI LTD.
2017 Harper, R., Cockshell, M., Bonder, C., & Reynolds, P. (2017). Culture of PAH peripheral blood derived endothelial progenitor cells allows isolation of exosomes and analysis of their surface markers. Poster session presented at the meeting of Abstracts of the International Conference of the American Thoracic Society (ATS 2017), as published in American Journal of Respiratory and Critical Care Medicine. New York, NY: American Thoracic Society.
2017 Harper, R., Cockshell, M., Bonder, C., & Reynolds, P. (2017). Isolation of exosomes and analysis of their surface markers from PAH peripheral blood derived Endothelial Progenitor Cells. Poster session presented at the meeting of Abstracts of the of the Australasia Extracellular Vesicle Conference. ASN Events.
2017 Harper, R., Cockshell, M., Bonder, C. S., & Reynolds, P. N. (2017). Culture of PAH peripheral blood derived endothelial progenitor cells allows isolation of exosomes and analysis of their surface markers. Poster session presented at the meeting of Abstracts of The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting 2017, as published in Respirology. Canberra, Australia: Wiley.
DOI
2017 Harper, R. L., Bonder, C., & Reynolds, P. (2017). Vascular remodelling is reversed following BMPR2 modified endothelial progenitor cell therapy in a MCT-induced PAH rat model. Poster session presented at the meeting of Proceedings of The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ)Annual Scientific Meeting, 2017, as published in Respirology. Canberra, ACT: Wiley.
2016 Harper, R. L., Ward, R., Bonder, C. S., & Reynolds, P. N. (2016). Vascular remodelling is reversed following BMPR2 modified endothelial progenitor cell therapy in a MCT-induced PAH rat model. Poster session presented at the meeting of ERS International Congress 2016 abstracts, as published in European Respiratory Journal. London, UK: European Respiratory Society.
DOI
2016 Rojas-Canales, D., Penko, D., Peiris, H., Pitson, S., Drogemuller, C., Keating, D., . . . Jessup, C. F. (2016). Sphingosine-1-phosphate promotes the migration of intraislet vascular cells: implications for post-transplant islet function. Poster session presented at the meeting of TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS.
2016 Yang, G. N., Bonder, C., Kopecki, Z., & Cowin, A. J. (2016). Flightless I regulates proliferation of cutaneous epithelial stem cells during wound repair. Poster session presented at the meeting of Wound repair and regeneration. US: Wiley-Blackwell Publishing.
2016 Campaniello, M., Mavrangelos, C., Dimasi, D., Hofma, B., Eade, S., Smid, S., . . . Hughes, P. A. (2016). Innate cell infiltration during acute TNBS colitis alters enteric nerve activity. Poster session presented at the meeting of Gastroenterology. San Diego, CA: Elsevier Inc..
DOI
2012 Ruzehaji, N., Kopecki, Z., Appleby, S. L., Bonder, C. S., Fitridge, R., & Cowin, A. J. (2012). ABLATION OF FLIGHTLESS PROTEIN IMPROVES HEALING IN A MURINE MODEL OF TYPE 1 DIABETES THROUGH INCREASED ANGIOGENESIS IN THE WOUNDS. Poster session presented at the meeting of WOUND REPAIR AND REGENERATION. WILEY-BLACKWELL.
2012 Brice, S. L., Thompson, E., Cockshell, M. P., Sen, S., & Bonder, C. S. (2012). Circulating human progenitor cells - the sentinels of vascular repair?. Poster session presented at the meeting of Abstracts and Posters of the 6th European Meeting on Vascular Biology and Medicine (EMVBM), as published in Vascular Pharmacology. Krakow, Poland: Elsevier.
DOI

Year Citation
2017 Lopez, A. F., Bonder, C. S., & Thompson, E. (2017). WO2017027898, Novel cancer treatment involving modulation of il-3 activity.
2017 Moore, E., Benveniste, G. L., & Bonder, C. S. (2017). WO2017156593, Medical devices using coated polymers.
2016 Voelcker, N. H., Moore, E., & Bonder, C. S. (2016). AU2016901008, Anti-fouling and/or anti-thrombotic medical devices.
2015 Bonder, C. S., & Lopez, A. F. (2015). WO2015168750, Method of culturing cells.
2013 Bonder, C. S., López, Á. F., & Talbo, G. H. (2013). EP2635674, Markers of endothelial progenitor cells and uses thereof.

Year Citation
2016 Harper, R. L. (2016). Gene therapy for Pulmonary Arterial Hypertension with Bone Morphogenetic Protein Receptor Type-2 modulation via engineered endothelial progenitor cells or a targeted Adeno-viral construct: changes in Smad and non-Smad signalling contributed to amelioration of disease.

Year Citation
2025 Liu, J., Geremew, D., Sandeman, L. Y., Nankivell, V. A., Chen, R., Xiang, L., . . . Bursill, C. A. (2025). Development of a novel murine model of in-stent neoatherosclerosis.
DOI
2021 Martini, C., DeNichilo, M., King, D., Cockshell, M., Ebert, B., Dale, B., . . . Bonder, C. (2021). CD36 Promotes Vasculogenic Mimicry in Melanoma by Mediating Adhesion to the Extracellular Matrix.
DOI

  • Advancing a new targeted antibody to combat pancreatic cancer, PanKind Australia - New Treatment Grant, 16/12/2024 - 31/01/2027

  • Enhancing the entry of therapeutic CAR-T cells into brain tumours, Neurosurgical Research Foundation, 01/08/2025 - 30/01/2027

  • CRC-P: Internal Testing and assessment of CAR-T cells using in vitro methods and in vivo animal tumour models, UniSA-Internal, 29/02/2020 - 30/06/2026

  • Enhancing Skin Cancer Diagnosis and Treatment through biomarker discovery, Tour de Cure Ltd, 01/01/2025 - 31/12/2025

  • Advancing a novel early detection biomarker for pancreatic cancer, Tour de Cure Ltd, 01/03/2022 - 31/12/2025

  • Investigating the tumour features that promote ICI therapy resistance in advanced melanoma, Australian Melanoma Research Foundation, 01/07/2025 - 31/12/2025

  • Exploiting blood vessels as conduits for the entry of therapeutic CAR-T cells into brain tumours, Neurosurgical Research Foundation, 02/10/2023 - 31/10/2025

  • MTA_ATCC - Spatial proteomics to define tumour microenvironments , Unknown, 11/10/2022 - 11/10/2024

  • Desmoglein-2; an unsuspected regulator of melanoma, NHMRC - Project Grant, 01/01/2019 - 31/12/2022

  • Investigating a novel adhesion molecule in pancreatic cancer, PanKind Australia - New Treatment Grant, 01/01/2022 - 31/10/2022

  • Engineered cell and exosome therapy for pulmonary vascular disease, NHMRC - Project Grant, 01/01/2018 - 31/12/2021

  • Targeting the IL-3/IL-3 receptor axis to prevent breast cancer progression., CA-Priority-driven Collaborative Cancer Research Scheme, 01/05/2016 - 31/03/2020

  • Desmoglein-2: A novel lifeline to treat diabetes, NHMRC - Project Grant, 01/01/2016 - 31/12/2019

  • Checkpoint blockade immunotherapy in melanoma: getting tumour-killing T cells to their site of action, Royal Adelaide Hospital, 01/01/2016 - 31/03/2017

  • Validation of a novel therapeutic target in multiple myeloma, Royal Adelaide Hospital, 01/01/2016 - 31/03/2017

Date Role Research Topic Program Degree Type Student Load Student Name
2019 - 2023 Co-Supervisor Inhibitory and metabolic effects of diabetes on yolk sac-derived endothelial-macrophage progenitors in postnatal murine tissues Doctor of Philosophy Doctorate Full Time Ms Sanuri Rashmitha Liyanage
2018 - 2022 External Supervisor Discovery and characterisation of yolk-sac derived Endothelial-Macrophage progenitor cells in postnatal murine tissues Doctor of Philosophy Doctorate Full Time Miss Anna Emilie Williamson
2012 - 2017 Co-Supervisor Roles and Regulation of Sphingosine Kinase 2 in Cancer Doctor of Philosophy Doctorate Part Time Heidi Anne Neubauer
2012 - 2016 Co-Supervisor GENE THERAPY FOR PULMONARY ARTERIAL HYPERTENSION WITH BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-2 MODULATION VIA ENGINEERED ENDOTHELIAL PROGENITOR CELLS OR A TARGETED ADENO-VIRAL CONSTRUCT: CHANGES IN SMAD AND NON-SMAD SIGNALLING CONTRIBUTED TO AMELIORATION OF DISEASE Doctor of Philosophy Doctorate Full Time Ms Rebecca Lea Harper
2010 - 2015 Principal Supervisor Sphingosine Kinase-1 Regulates Neutrophil Recruitment During Allergic Inflammation Doctor of Philosophy Doctorate Full Time Miss Wai Yan Sun
2007 - 2012 Co-Supervisor Endothelial Progenitor Cells, Uraemic Toxins and the Development of Endothelial Dysfunction in Chronic Kidney Disease Doctor of Philosophy Doctorate Part Time Dr Shaundeep Sen
2006 - 2010 Co-Supervisor Regulation of Sphingosine Kinase by Interacting Proteins Doctor of Philosophy Doctorate Full Time Dr Tamara Leclercq

Connect With Me

External Profiles

Other Links